Medindia
Medindia LOGIN REGISTER
Advertisement

Following Its Recent Approval in the United States and Europe for Osteoporosis, Prolia Will Garner Sales of More than $500 Million in 2019

Tuesday, July 6, 2010 General News
Advertisement
Prolia's Uptake Will Be Constrained by Its Premium Price and the Increasing Availability of Generic Drugs, According to Findings from Decision Resources

For more information, contact:

Decision Resources, Inc.

Christopher Comfort

781-296-2597

[email protected]

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close